摘要
目的：探讨腹膜透析相关性腹膜炎的治疗。方法：回顾性分析的89例腹膜透析相关性腹膜炎患者，初期使用头孢菌素和或氨基糖甙类抗生素治疗，严重者使用头孢唑林和头孢他啶治疗。结果：89例腹膜炎患者透析液培养阳性33例（37．1％），其中19例1～4d治愈（21．3％），56例4～14d治愈（62．9％），复发11例（12．4％），2例因尿毒症而全身衰竭死亡（2．2％）。结论：虽然腹膜透析相关性腹膜炎的发病率有降低趋势，但其仍然是腹膜透析最常见并发症之一，我们在强调对腹膜炎治疗的同时，更要强调对腹膜炎的预防。
Objective： To evaluate the benefits of treatments for peritoneal dialysis-associated peritonitis. Methods： We retrospectively studied the medical records of 89 patients who continued PD beyond 2 months. Peritonitis episodes were treated with a standard antibiotic protocol of our centre. Initial antibiotics for peritonitis were generally intra-peritoneal administration of cephalosporin and aminoglycoside, or cefazolin plus ceftazidime. Results： Within the observation period, 33 of the 89 peritonitis episodes were culture-positive （37.1%）. Dialysate cultures were negative in 56 of the total of 89 episodes of peritonitis （62.9%）. 19 cases were cured during 1 to 4 days（21.3% ）. 56 eases were cured during 4 to 14 days（62.9 %）. Eleven cases （12.4 % ） had recurrent peritonitis after antibiotic therapy. 2 patients died of uremia cause of death was multiple organ failure （2.2 %）. Conclusion： Peritonitis is still an important complication of peritoneal dialysis, although the incidence became lower. Concerned about the treatment of peritoneal dialysis-associated perionitis at the same time, we should emphasis its prevention.
出处
《华西医学》
CAS
2009年第7期1755-1757,共3页
West China Medical Journal
关键词
腹膜透析
腹膜炎
肾功能衰竭
peritoneal dialysis
peritonitis
renal failure
